Skip to main content

Published locations for FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves brentuximab vedotin for primary cutaneous anaplastic large cell lymphoma

User login

  • Reset your password
  • /content/fda-approves-brentuximab-vedotin-primary-cutaneous-anaplastic-large-cell-lymphoma
  • /hematologynews/article/151664/t-cell-lymphomas/fda-approves-brentuximab-vedotin-primary-cutaneous
  • /oncologypractice/article/151664/t-cell-lymphomas/fda-approves-brentuximab-vedotin-primary-cutaneous
  • /hematology-oncology/article/151664/t-cell-lymphomas/fda-approves-brentuximab-vedotin-primary